EU regulator backs use of Novo's Wegovy for obesity-related heart condition - Reuters

Reuters | Sept. 19, 2024, 5:25 p.m. | Original
EU regulator backs use of Novo's Wegovy for obesity-related heart condition Reuters
Chevron not looking to invest in building US LNG plants, official says - Reuters Nike's Hill to return as CEO, Donahoe to retire; shares rise - Reuters